Bioinduction Limited
04429471
Details
Compliance
Last accounts
31/12/2023
total exemption full
Accounts
Confirmation statement
Last: 12/03/2025
Due
Industry
Officers
director · Since 25/07/2023
ENTREPRENEUR
BRITISH · ENGLAND · Age 42
Also on 4 other boards
director · Since 25/07/2023
PROFESSOR OF ENGINEERING SCIENCE
AMERICAN · ENGLAND · Age 55
Also on 1 other board
Persons with Significant Control
Amber Therapeutics Ltd
42, Sutherland Place, London, W2 5BY
Reg: 13089338 · United Kingdom · Company Limited By Shares
Notified 25/07/2023
Amber Therapeutics Holdings Limited
Cannon Place, 78 Cannon Street,, Cannon Place, London, EC4N 6AF
Reg: 13089338 · Uk · Limited Company
Notified 11/07/2024
Former PSCs
Mr Ivor Stephen Gillbe
Ceased 25/07/2023
CompanyRankvs 15+ SIC 26600 peers42
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2023
Net Worth
£144k
Balance sheet strength
Cash
£161k
Cash in the bank
Net Current Assets
£148k
Working capital
Current Assets
£860k
Current Liabilities
£712k
Fixed Assets
£8k
Debtors
£677k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 1.21 | +£138k |
| 2023 | 1.00 | -£461k |
| 2022 | 5.91 | +£260k |
| 2021 | 4.93 | -£117k |
| 2020 | 6.21 | +£108k |
| 2019 | 1.57 | -£333k |
| 2017 | 7.41 | — |
Derived from filed accounts. Not audited figures.